18
Participants
Start Date
March 19, 2024
Primary Completion Date
October 15, 2025
Study Completion Date
July 22, 2026
TAK-279
Specified drug on specified days.
Nagoya City University Hospital, Nagoya
Fujita Health University Hospital, Toyoake
Kimitsu Chuo Hospital, Kisarazu
Juntendo University Urayasu Hospital, Urayasu
Hospital of the University of Occupational and Environmental Health, Japan, Kitakyushu
Isesaki Municipal Hospital, Isesaki
Kobe University Hospital, Kobe
Tokai University Hospital, Isehara
Mie University Hospital, Tsu
Kansai Medical University Hospital, Hirakata
Saitama Medical University Hospital, Iruma
St.Luke's International Hospital, Chūō
Teikyo University Hospital, Itabashi-ku
The Jikei University Hospital, Minato-ku
Tokyo Medical University Hospital, Shinjuku-ku
Fukuoka University Hospital, Fukuoka
University Hospital, Kyoto Prefectural University of Medicine, Kyoto
Okayama University Hospital, Okayama
Nippon Life Hospital, Osaka
Osaka Metropolitan University Hospital, Osaka
Lead Sponsor
Takeda
INDUSTRY